Depression and Anxiety Trial, Not Yet Recruiting NCT06718231 Sponsor: Fuling Central Hospital of Chongqing City Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT06718231
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are having a one-sided keyhole lung surgery (called VATS) under general anaesthesia to investigate or remove spots found on the lung.
  • People aged between 18 and 65 years old.
  • People whose general health has been rated by an anaesthesiologist as falling into category II or III on a standard health scale (meaning they have mild to moderate health conditions, but are not critically ill).
  • People who are fully conscious, have no facial paralysis, are able to cooperate with the study procedures, and have signed a consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a skin infection at or near the specific body points used in the treatment.
  • People who have nerve damage or injury in their upper arms or hands.
  • People who have an implanted pacemaker (a device placed in the chest to help the heart beat regularly).
  • People with a history of alcoholism, or those who have been regularly using opioid painkillers, hormone treatments, or anti-inflammatory pain medicines.
  • People who have a known allergy to any of the medicines being used in this study.
  • People who have recently received a type of electrical acupoint stimulation therapy (TAES) or any other acupoint treatment (confirm with trial site for specific timeframe).
  • People who have a history of psychiatric disorders or who are currently taking psychiatric medications.
  • People who are currently being treated with a type of medicine called monoamine oxidase inhibitors (MAOIs).
  • People who have serious disease affecting the heart, brain, liver, kidneys, or blood-forming system.
  • People who are unable to cooperate with the study requirements for any reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615213680591

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Fuling Central Hospital of Chongqing City
Registry
ClinicalTrials.gov
Start date
20 December 2024
Est. completion
20 January 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Beck Depression Inventory score 30 days postoperatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov